Critical review of the role of HTS in drug discovery.
暂无分享,去创建一个
[1] R. Spencer,et al. High-throughput screening of historic collections: observations on file size, biological targets, and file diversity. , 1998, Biotechnology and bioengineering.
[2] Ulf Bömer,et al. High‐Throughput Screening for Kinase Inhibitors , 2005, Chembiochem : a European journal of chemical biology.
[3] Christian Eggeling,et al. Highly sensitive fluorescence detection technology currently available for HTS. , 2003, Drug discovery today.
[4] Valler,et al. Diversity screening versus focussed screening in drug discovery. , 2000, Drug discovery today.
[5] Mark C. Fishman,et al. Pharmaceuticals: A new grammar for drug discovery , 2005, Nature.
[6] Mark S Butler,et al. The role of natural product chemistry in drug discovery. , 2004, Journal of natural products.
[7] Ricardo Macarron,et al. Novel antibacterials: a genomics approach to drug discovery. , 2002, Current drug targets. Infectious disorders.
[8] Marc Boillat,et al. Precise nanoliter fluid handling system with integrated high-speed flow sensor. , 2005, Assay and drug development technologies.
[9] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[10] S. Fox,et al. High-Throughput Screening: Searching for Higher Productivity , 2004, Journal of biomolecular screening.
[11] Paul B Taylor,et al. A Standard Operating Procedure for Assessing Liquid Handler Performance in High-Throughput Screening , 2002, Journal of biomolecular screening.
[12] G. Sitta Sittampalam,et al. Design of Signal Windows in High Throughput Screening Assays for Drug Discovery , 1997 .
[13] Phillip Gribbon,et al. High-throughput drug discovery: what can we expect from HTS? , 2005, Drug discovery today.
[14] Andrew M Davis,et al. Components of successful lead generation. , 2005, Current topics in medicinal chemistry.
[15] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[16] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[17] Sandra Fox,et al. High Throughput Screening 2002: Moving Toward Increased Success Rates , 2002, Journal of biomolecular screening.